• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies.

作者信息

Pagano Livio, Caira Morena, Trecarichi Enrico Maria, Spanu Teresa, Di Blasi Roberta, Sica Simona, Sanguinetti Maurizio, Tumbarello Mario

出版信息

Emerg Infect Dis. 2014 Jul;20(7):1235-6. doi: 10.3201/eid2007.130094.

DOI:10.3201/eid2007.130094
PMID:24960464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4073839/
Abstract
摘要

相似文献

1
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies.产碳青霉烯酶肺炎克雷伯菌与血液系统恶性肿瘤
Emerg Infect Dis. 2014 Jul;20(7):1235-6. doi: 10.3201/eid2007.130094.
2
[Phenotypic and molecular detection of carbapenemase-producing Klebsiella pneumoniae strains].
Med Mal Infect. 2019 May;49(3):225-226. doi: 10.1016/j.medmal.2018.10.010. Epub 2018 Nov 22.
3
In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.2015-2016 年在希腊医院分离的产非 MBL 碳青霉烯酶肺炎克雷伯菌的亚胺培南-雷利巴坦体外活性。
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1143-1150. doi: 10.1007/s10096-019-03517-y. Epub 2019 Mar 1.
4
Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report.日本患者分离的产碳青霉烯酶肺炎克雷伯菌（KPC）ST258株，无境外旅行史——日本新的公共卫生关注点：病例报告。
BMC Infect Dis. 2019 Jan 7;19(1):20. doi: 10.1186/s12879-018-3649-9.
5
Using an intensified infection prevention intervention to control carbapenemase-producing Enterobacteriaceae at a Thai center.在泰国一家医疗中心采用强化感染预防干预措施来控制产碳青霉烯酶肠杆菌科细菌。
Infect Control Hosp Epidemiol. 2012 Sep;33(9):960-1. doi: 10.1086/667386.
6
Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016.2016年，意大利，ST16型肺炎克雷伯菌同时产生NDM-1和OXA-232。
Future Microbiol. 2017 Oct;12:1119-1122. doi: 10.2217/fmb-2017-0041. Epub 2017 Sep 6.
7
The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York.产碳青霉烯酶肺炎克雷伯菌在纽约州北部的传播。
Clin Infect Dis. 2006 Aug 1;43(3):e26-8. doi: 10.1086/505598. Epub 2006 Jun 19.
8
Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases.产 NDM 型和 OXA-181 碳青霉烯酶肺炎克雷伯菌的出现。
Clin Microbiol Infect. 2013 Sep;19(9):E421-3. doi: 10.1111/1469-0691.12247. Epub 2013 May 13.
9
Klebsiella pneumoniae co-producing NDM-5 and OXA-181 carbapenemases, South Korea.韩国发现产NDM-5和OXA-181碳青霉烯酶的肺炎克雷伯菌。
Emerg Infect Dis. 2015 Jun;21(6):1088-9. doi: 10.3201/eid2106.150048.
10
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy.一株来自意大利的携带KPC-1的耐碳青霉烯类肺炎克雷伯菌分离株。
New Microbiol. 2010 Jul;33(3):281-2.

引用本文的文献

1
Impact of ceftazidime-avibactam on mortality in bloodstream infections: a cohort study in patients with acute leukemia.头孢他啶-阿维巴坦对血流感染患者死亡率的影响：一项针对急性白血病患者的队列研究。
Ther Adv Infect Dis. 2025 Aug 16;12:20499361251362955. doi: 10.1177/20499361251362955. eCollection 2025 Jan-Dec.
2
Multidrug-resistant ST11-KL64 hypervirulent with multiple genes isolated from children's blood.从儿童血液中分离出的具有多种基因的多重耐药ST11-KL64高毒力菌株
Front Pediatr. 2025 Jan 6;12:1450201. doi: 10.3389/fped.2024.1450201. eCollection 2024.
3
Clinical and genomic characterization of carbapenem-resistant bloodstream infections in patients with hematologic malignancies.血液恶性肿瘤患者碳青霉烯类耐药血流感染的临床和基因组特征。
Front Cell Infect Microbiol. 2024 Sep 26;14:1471477. doi: 10.3389/fcimb.2024.1471477. eCollection 2024.
4
Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients.血液恶性肿瘤和造血细胞移植受者的抗菌耐药全球影响。
Transpl Infect Dis. 2023 Nov;25 Suppl 1(Suppl 1):e14169. doi: 10.1111/tid.14169. Epub 2023 Oct 20.
5
Oral colonization by gram-negative bacilli in patients with hematologic malignancies and solid tumors compared with healthy controls.血液恶性肿瘤和实体瘤患者与健康对照者革兰阴性杆菌的口腔定植比较。
BMC Oral Health. 2023 Jul 8;23(1):465. doi: 10.1186/s12903-023-03172-y.
6
Decrease in Mortality from Sepsis: Impact of the Multidisciplinary Program for the Hematologic Patient at Very High Risk.脓毒症死亡率的降低：针对极高风险血液学患者的多学科项目的影响
Indian J Hematol Blood Transfus. 2023 Jan;39(1):7-14. doi: 10.1007/s12288-021-01497-8. Epub 2021 Oct 18.
7
Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy.评估头孢他啶/阿维巴坦对携带OXA-48和/或NDM基因的产碳青霉烯酶耐碳青霉烯类肠杆菌科细菌的治疗效果，无论是否联合治疗。
JAC Antimicrob Resist. 2022 Oct 11;4(5):dlac104. doi: 10.1093/jacamr/dlac104. eCollection 2022 Oct.
8
Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Bloodstream Infections.耐碳青霉烯类血流感染的血液系统恶性肿瘤患者的死亡及预后危险因素
Infect Drug Resist. 2022 Aug 4;15:4241-4251. doi: 10.2147/IDR.S374904. eCollection 2022.
9
Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients.多部位定植筛查培养预测血液科患者的多重耐药革兰阴性和革兰阳性菌血症。
BMC Infect Dis. 2022 Feb 21;22(1):172. doi: 10.1186/s12879-022-07154-3.
10
Clinical Characteristics and Risk Factors for Critically Ill Patients with Carbapenem-Resistant (CrKP): A Cohort Study from Developing Country.耐碳青霉烯类肺炎克雷伯菌（CrKP）重症患者的临床特征及危险因素：一项来自发展中国家的队列研究
Infect Drug Resist. 2021 Dec 20;14:5555-5562. doi: 10.2147/IDR.S343489. eCollection 2021.

本文引用的文献

1
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.碳青霉烯类耐药肠杆菌科细菌作为血液恶性肿瘤患者血流感染的病因出现。
Leuk Lymphoma. 2013 Apr;54(4):799-806. doi: 10.3109/10428194.2012.723210. Epub 2012 Sep 14.
2
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.产碳青霉烯酶肺炎克雷伯菌血流感染患者的死亡率预测因素：联合治疗的重要性。
Clin Infect Dis. 2012 Oct;55(7):943-50. doi: 10.1093/cid/cis588. Epub 2012 Jul 2.
3
Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.产 KPC 肺炎克雷伯菌血症的治疗转归：联合抗菌方案的优势。
Antimicrob Agents Chemother. 2012 Apr;56(4):2108-13. doi: 10.1128/AAC.06268-11. Epub 2012 Jan 17.
4
Factors associated with mortality in bacteremic patients with hematologic malignancies.血液系统恶性肿瘤菌血症患者死亡的相关因素。
Diagn Microbiol Infect Dis. 2009 Jul;64(3):320-6. doi: 10.1016/j.diagmicrobio.2009.02.008. Epub 2009 Apr 2.
5
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.血液系统恶性肿瘤患者中由大肠埃希菌引起的血流感染中，超广谱β-内酰胺酶（ESBL）产生及氟喹诺酮耐药的发生率和临床影响。
J Infect. 2009 Apr;58(4):299-307. doi: 10.1016/j.jinf.2009.02.002. Epub 2009 Mar 9.